CellProTx
Aberdeen, Scotland*
Cell ProTx is a pre-clinical stage biotechnology company developing new treatments to protect human cells and tissue from damage. The company is addressing areas of significant unmet medical need in oncology by reducing the incidence of collateral damage to healthy tissue in the vicinity of tumours undergoing radiotherapy.
*IHIF and the Scottish Lifesciences Association provide reciprocal benefits to our member companies. Learn more about the partnership and our other international members here.